ai·MIT Tech Review·8d ago

Eating disorders are on the rise. GLP-1s could make things worse.

Aggregated Excerpt & Summary

GLP-1 weight-loss drugs are one of the biggest biotech breakthroughs of the last decade. But to some clinical psychologists, they can represent something more sinister—a potential trigger for eating disorders. A new repo...

Read Complete Article at MIT Tech Review

Fair-Use & Aggregation Notice: The Vartaa indexes headlines and short excerpts solely to facilitate community commentary. All rights remain with the original publishers. Full reporting is accessible via the source links above.

Discussion

Moderated community discourse. One-level threading, authenticated voting, and spam protected.

Realtime Stream

Authentication Required to Post

To maintain high-signal discussion and prevent automated spam, anonymous commenting is disabled.

No comments yet

Be the first to share an informed perspective on this story.

Loading story discussion thread...